Energy results are as diverse as the industry itself, and Motley Fool’s Tyler Crowe, Taylor Muckerman and Sean O’Reilly weigh in.

Energy results are as diverse as the industry itself, and Motley Fool’s Tyler Crowe, Taylor Muckerman and Sean O’Reilly weigh in.

On this episode we talk earnings numbers, some cool stats from the conference call and check in on Facebook’s other big internet properties.

Motley Fools dig into recent announcements that could impact the marijuana and hepatitis C markets next year.

Motley Fools dig into recent announcements that could impact the marijuana and hepatitis C markets next year.

On this episode we dig into Apple’s record-setting quarter, explain why the market shouldn’t have been surprised, and figure out what segments fueled the company’s great top and bottom line growth.

On this episode we dig into Apple’s record-setting quarter, explain why the market shouldn’t have been surprised, and figure out what segments fueled the company’s great top and bottom line growth.

Oil sands are becoming more common in the energy sector, and with the amount of work it takes to clean these sands, it's no wonder the cost is so high. Shell not only dropped out of the Arctic after building up all the hype, but now they're letting go of oil sands projects, citing the company's business structure as the problem.

All the while, a "cash crunch" is enveloping the Fab Four in the oil and gas sector, but although these numbers are huge to a layperson, their cash reserves seem to be singing a different tune.

Oil sands are becoming more common in the energy sector, and with the amount of work it takes to clean these sands, it's no wonder the cost is so high. Shell not only dropped out of the Arctic after building up all the hype, but now they're letting go of oil sands projects, citing the company's business structure as the problem.

All the while, a "cash crunch" is enveloping the Fab Four in the oil and gas sector, but although these numbers are huge to a layperson, their cash reserves seem to be singing a different tune.

This week we're discussing Walgreens acquiring Rite Aid. Did this retail pharmacy giant play its cards right? Does an overlapping footprint mean the two retail pharmacies will step on each other’s toes? Tune in to find some answers.